ArticleFrontiers in endocrinology2025
Re-evaluating basophil count as a hematological indicator for bone density: a subgroup analysis from an East Asian population.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: While traditional risk factors for osteoporosis such as age, sex, and menopause are well-established, emerging evidence suggests that immune cells may also influence bone metabolism. Among them, the role of basophils remains poorly understood. This study investigated the association between peripheral blood basophil count and lumbar spine bone mineral density (BMD) in an East Asian adult population. Methods: A retrospective analysis was conducted on 200 adults undergoing health check-ups and lumbar dual-energy X-ray absorptiometry. Basophil count and other hematologic and biochemical parameters were correlated with lumbar spine T-scores using multivariate regression. Results: Basophil count showed no significant correlation with T-scores in the overall cohort (r = 0.06, p = 0.4261). However, a weak inverse trend was noted in participants with BMI ≥ 27. In contrast, GPT and creatinine were significantly associated with BMD, with alanine aminotransferase (GPT) emerging as a strong independent predictor (β = 0.61, p < 0.001). Conclusions: Basophil count does not appear to be a reliable biomarker for BMD in the general population. However, findings in the higher-BMI subgroup suggest a potential link that warrants further investigation. GPT may hold greater utility as a surrogate marker for bone health in clinical screening. The present findings also highlight the value of publishing negative results and underscore the need for future research in larger and more diverse cohorts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.